Introduction to the special issue on adverse outcome pathways in radiation protection
Introduction to the special issue on adverse outcome pathways in radiation protection
复制标题
辐射防护不良后果途径特刊介绍
DOI:
10.1080/09553002.2022.2123183
复制
发表时间:
2022
影响因子:
2.6
通讯作者:
N. Hamada
中科院分区:
文献类型:
--
作者:
V. Chauhan;O. Azimzadeh;S. Salomaa;N. Hamada
This special issue of the International Journal of Radiation Biology entitled ‘Adverse Outcome Pathways in Radiation Protection’is inspired by growing global interest in approaches for integrating information from radiation biology and epidemiology to improve scientific understanding of low dose radiation health risk assessment. The adverse outcome pathway (AOP) represents a conceptual framework characterizing a stressor associated with a sequential set of causally linked key events at different levels of biological organization, beginning with a molecular initiating event and culminating in an adverse health outcome. The special issue provides a comprehensive overview of AOPs, a summary of origin, the goals of a newly formed topical group, current case examples of AOPs and how the radiation field can harness AOPs to structure the available knowledge on the biological effects of radiation exposure. The special issue consists of a commentary (Chauhan, Beaton, et al. 2022), four reviews (Azimzadeh et al. 2022; Chauhan, Hamada, Wilkins, et al. 2022; Chauhan, Hamada, Garnier-Laplace, et al. 2022; Jaylet et al. 2022) and seven research articles (Adam et al. 2022; Burtt et al. 2022; Klokov et al. 2022; Kozbenko et al. 2022; Stainforth et al. 2022; Tollefsen et al. 2022; Yu et al. 2022).It is envisioned that AOPs could contribute toward better delineating and defining early mechanistic changes and a sequence of events from radiation exposures that are causally linked to health outcomes relevant to public and ecosystem protection. The data informing AOPs could then be used for designing robust bioassays and risk model strategies relevant to regulatory decision-making. However, before this goal is reached, some important questions need to be addressed as to how different types, doses and dose rates of radiation exposure can accurately inform AOP development and how AOPs can reflect the latency of adverse health outcomes in a simplified form. These and other questions posed by the radiation community can only be addressed through practical AOP construction, and through shared experiences from the AOP experts in the chemical toxicology field.